FI50422C - Förfarnde för framställning av farmakologiskt verksamma subtituerade p iperidinoalkyltianaftener och -bensofuraner - Google Patents

Förfarnde för framställning av farmakologiskt verksamma subtituerade p iperidinoalkyltianaftener och -bensofuraner

Info

Publication number
FI50422C
FI50422C FI680559A FI55968A FI50422C FI 50422 C FI50422 C FI 50422C FI 680559 A FI680559 A FI 680559A FI 55968 A FI55968 A FI 55968A FI 50422 C FI50422 C FI 50422C
Authority
FI
Finland
Prior art keywords
overthianaphthenes
piperidinoalkyl
benzofurans
preparation
pharmacologically active
Prior art date
Application number
FI680559A
Other languages
English (en)
Finnish (fi)
Other versions
FI50422B (sv
Inventor
Carl Kaiser
Charles Leon Zirkle
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of FI50422B publication Critical patent/FI50422B/fi
Application granted granted Critical
Publication of FI50422C publication Critical patent/FI50422C/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FI680559A 1967-03-06 1968-03-01 Förfarnde för framställning av farmakologiskt verksamma subtituerade p iperidinoalkyltianaftener och -bensofuraner FI50422C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62062867A 1967-03-06 1967-03-06
US66970767A 1967-09-22 1967-09-22

Publications (2)

Publication Number Publication Date
FI50422B FI50422B (sv) 1975-12-01
FI50422C true FI50422C (sv) 1976-03-10

Family

ID=27088751

Family Applications (1)

Application Number Title Priority Date Filing Date
FI680559A FI50422C (sv) 1967-03-06 1968-03-01 Förfarnde för framställning av farmakologiskt verksamma subtituerade p iperidinoalkyltianaftener och -bensofuraner

Country Status (6)

Country Link
DK (1) DK120387B (sv)
ES (1) ES350880A1 (sv)
FI (1) FI50422C (sv)
IE (1) IE32098B1 (sv)
IL (1) IL29437A (sv)
SE (1) SE342040B (sv)

Also Published As

Publication number Publication date
IL29437A (en) 1971-11-29
SE342040B (sv) 1972-01-24
ES350880A1 (es) 1969-05-16
FI50422B (sv) 1975-12-01
DK120387B (da) 1971-05-24
IE32098B1 (en) 1973-04-18
IE32098L (en) 1968-09-06

Similar Documents

Publication Publication Date Title
IT7827783A0 (it) Fenacetil-guanidine e loro preparazione.
FI50707C (sv) Förfarande för framställning av nya farmakologiskt aktiva hydroxicyklo hexylaminer.
BR6913699D0 (pt) Compostos farmaceuticamente ativos
DE1756948B2 (de) Eintraegerlaufkran
IT1062053B (it) Amminoguanidine farmaceuticamente attive procedimento per la loro preparazione e composizioni farmaceutiche che le commengomo
FI48930C (sv) Förfarande för framställning av nya terapeutiskt aktiva derivat av 3-( 5-nitro-2-furyl)-2-isoxazoliner.
NO141807C (no) Fremgangsmaate for fremstilling av aktiv toerrgjaer
IT1061026B (it) Nitroimmidazoli e procedimento per la loro preparazione
IT1008508B (it) Agenti antibatterici e procedimento per la loro produzion
OA02879A (fr) Benzènesulfonyl-semicarbazides et leur préparation.
CH477231A (de) Wirbelmühle
FR1505241A (fr) Thiocyano-pyrroles substitués et leur préparation
BR6456693D0 (pt) Processo para a preparacao de benzimidazois fisiologicamente ativos
FI50422C (sv) Förfarnde för framställning av farmakologiskt verksamma subtituerade p iperidinoalkyltianaftener och -bensofuraner
BR6683481D0 (pt) Compostos farmacologicamente ativos e o processo da sua obtencao
BR6804170D0 (pt) Preparacao de salicilanilidas e tio-salicilanidas substituidas
AT273608B (de) Metallisierung von geformten Gebilden
FI50420C (sv) Förfarande för framställning av terapeutiskt aktiva 4-pyrimidinyl-1,4- dihydropyridinderivat
FI48084C (sv) Förfarande för framställning av 1-metyl-5-nitroimidazol-2-yl-karbamate r
IT1046929B (it) Derivati del pregnano e procedimento per la loro preparazione
FI45175C (sv) Förfarande för framställning av 18-metyl-19-nor-17alfa-hydroxi-progest eroner och deras 17alfa-estrar.
FI47661C (sv) Förfarande för framställning av terapeutiskt verkande bensofuranderiva t.
FI49400C (sv) Analogiförfarande för framställning av nya terapeutiskt verksamma cykl opeptider.
BR6801380D0 (pt) Preparacao de tabletes
FI51188C (sv) Förfarande för framställning av farmakologiskt verkande substituerade 2-oxo-bensotiazolin- och bensoimidazolinföreningar.